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Negative Regulation
of BMP/Smad Signaling
by Tob in Osteoblasts
bacher et al., 1995). This process occurring in adult
bone is called bone remodeling. Bone remodeling is
accomplished by precise coordination of two cell types,
osteoblasts and osteoclasts. Osteoblasts deposit calci-
fied bone matrix, and osteoclasts resorb it. Deregula-
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Bone morphogenetic proteins (BMPs), which areJapan
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However, molecular basis of the function of BMPs re-Japan
mains to be further analyzed. BMPs signal through het-
eromeric complexes of transmembrane type I and type
II Ser/Thr kinase receptors that then propagate signalsSummary
to the Smad pathway. Smad proteins play a critical role
in mediating BMP-induced signals from the cell surfaceBone morphogenetic protein (BMP) controls osteo-
to the nucleus. Smads are subdivided into three classes:blast proliferation and differentiation through Smad
receptor-regulated Smads (R-Smads), common Smadsproteins. Here we show that Tob, a member of the
(Co-Smads), and inhibitory Smads (I-Smads), each ofemerging family of antiproliferative proteins, is a nega-
which has a distinct function. R-Smads (Smad1, 5, andtive regulator of BMP/Smad signaling in osteoblasts.
8) are phosphorylated by the type I receptor on theMice carrying a targeted deletion of the tob gene have
carboxy-terminal SSXS motif. Once phosphorylated,a greater bone mass resulting from increased numbers
R-Smads dissociate from the receptor, bind to Co-Smadof osteoblasts. Orthotopic bone formation in response
(Smad4), and enter the nucleus. In the nucleus, hetero-to BMP2 is elevated in tob-deficient mice. Overproduc-
meric Smad complexes function as effectors of BMPtion of Tob represses BMP2-induced, Smad-mediated
signaling by regulating transcription of specific genes.transcriptional activation. Finally, Tob associates with
Smads can specifically recognize target promoters byreceptor-regulated Smads (Smad1, 5, and 8) and colo-
associating with other DNA binding coactivators or core-calizes with these Smads in the nuclear bodies upon
pressors. The types of genes responsible for BMP-acti-BMP2 stimulation. The results indicate that Tob nega-
vated Smads are dependent on the tissue or cell type.tively regulates osteoblast proliferation and differenti-
Thus, Smads bind with different cofactors or corepres-ation by suppressing the activity of the receptor-regu-
sors in a manner specific to each cell type. It is notlated Smad proteins.
known how BMP-activated Smads recognize specific
target genes in each cell type.Introduction
Tob is a member of a novel antiproliferative protein
family consisting, in human, of Tob, Tob2, ANA (BTG3Bone is formed and resorbed continuously, starting in
in mouse), BTG2 (PC3 in rat and TIS21 in mouse), andthe embryo and continuing throughout adult life (Erle-
BTG1 (Bradbury et al., 1991; Fletcher et al., 1991; Rou-
ault et al., 1992; Matsuda et al., 1996; Rouault et al.,#To whom correspondence should be addressed (e-mail: tyamamot@
ims.u-tokyo.ac.jp). 1996; Guehenneux et al., 1997; Yoshida et al., 1997,
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1998; Ikematsu et al., 1999). The family proteins (Tob/ lizing hormones or factors in vivo, we examined serum
levels of 1a,25(OH)2D3 and parathyroid hormone (PTH)BTG family proteins) suppress cell growth when ex-
pressed exogenously in NIH3T3 cells (Rouault et al., and mRNA levels of BMP2, BMP4, TGF-b1, IGF1, and
bFGF in bone marrow. All these levels in tob2/2 mice1992; Matsuda et al., 1996; Montagnoli et al., 1996; Yo-
shida et al., 1998; Ikematsu et al., 1999). However, the were similar to those in wild-type mice, indicating that
increased bone mass in tob2/2 mice was not due tobiological importance of Tob family proteins in vivo is
unclear. Here, we report that the Tob protein functions the alteration of these bone metabolizing hormones or
factors. These data suggest that Tob is directly involvedin the process of BMP2-dependent bone formation
through its ability to bind Smad1, Smad5, and Smad8. in either stimulation of bone formation or suppression
of bone resorption.
Results
Increased Osteoblast Surface and Bone Formation
Targeted Disruption of tob and Germline
Rate in tob-Deficient Mice
Transmission of the Mutated Allele
To determine whether the increase in trabecular bone
The murine tob gene was obtained from a genomic li-
mass was due to altered bone remodeling, we examined
brary constructed from 129/Sv mouse genomic DNA in
three markers: osteoblast surface (ObS/BS, proportion
l phage (Yoshida et al., 1997). The coding region of the
of bone surface covered with osteoblasts), osteoclast
mouse tob gene consists of only one exon (Figure 1A).
surface (OcS/BS, proportion of bone surface covered
The targeting vector contained a PGK-neo cassette for
with osteoclasts), and eroded surface (ES/BS, propor-
positive selection and a DT-A cassette for negative se-
tion of bone surface eroded by osteoclasts) in 4- and
lection against random integration of the targeting vec-
9-month-old mice. The osteoclast surface and eroded
tor. It also contained 10.5 kbp and 2 kbp genomic DNA
surface in tob2/2 mice were equivalent to those in wild-
flanking the neo cassette at 59 and 39 ends, respectively
type littermates (Figures 2B and 2C), suggesting that
(Figure 1A). J1 embryonic stem (ES) cells (Li et al., 1992)
increased bone mass in tob2/2 mice was not due to
were electroporated with the linearized targeting vector
reduced osteoclast numbers or impaired osteoclast
and subjected to neo selection. Among 160 indepen-
function. In contrast, the osteoblast surface, a reliable
dently selected ES cell clones, clones with correct gene
indicator of osteoblast population, was increased signif-
targeting were identified by Southern blot. Indepen-
icantly in tob2/2 mice and was 250% greater than that of
dently identified tob-targeted clones were injected into
wild type (Figure 2D). Furthermore, the double-labeling
C57BL/6 recipient blastocysts, and male chimeras ob-
analysis with calcein, a marker of newly formed bone,
tained were crossed to C57BL/6 females. Germline
showed that the bone formation rate was increased in
transmission of the ES cell genome was monitored by
the long bones of tob2/2 mice in comparison to that
inspection for agouti coat color and by Southern blot
of wild-type littermates (Figures 2E and 2F). Thus, we
hybridization analysis of genomic DNA obtained from
concluded that the increased bone mass in tob2/2 mice
mouse tails. Mice heterozygous for the disrupted tob
was due to increased osteoblast numbers and accelera-
allele (tob1/2) were crossed to obtain animals homozy-
tion of the bone formation rate.
gous for the mutation (tob2/2). Southern blot and West-
ern blot analyses revealed that the wild-type tob alleles
were disrupted (Figures 1B and 1C). Expression of tob in Osteoblasts
We examined tob expression in developing limbs from
d14.5 and d18.5 embryos by in situ hybridization analy-Increased Bone Mass in tob-Deficient Mice
Homozygous tob knockout (tob2/2) mice were alive at sis. Significant tob expression was detected in the peri-
osteum of the bone collar in the d14.5 bone rudimentbirth and were obtained at predicted Mendelian frequen-
cies. No apparent phenotypic abnormalities were ob- (data not shown) and in the d18.5 metatarsal bone (Fig-
ure 3A). These are the regions where bone is initiallyserved within a year after birth except that the bone
mass was increased compared with that of wild-type formed. tob transcripts were also found in the core re-
gion beneath the bone collar of the bone rudiment butlittermates. Microfocus X-ray computed tomography re-
vealed that the bone mass of tob2/2mice was approxi- not in the proliferating chondrocytes (Figure 3A). The
data suggest that tob was enriched in osteoblasts andmately 130% of that of control littermates at 2 months
of age (p , 0.01 Student’s t test, n54). Obvious increase was expressed moderately in hypertrophic chondro-
cytes. Northern blot analysis further showed tob to bewas not observed in the bone mass of mutant mice
compared to control mice at 2 weeks of age. Histological expressed in calvaria-derived osteoblasts and clonal
osteoblastic MC3T3 cells (Figure 3B). A relatively lowstudy of undecalcified sections of tibiae also showed
the increase in trabecular bone of tob2/2 mice (Figure level of tob mRNA was expressed in osteoclasts. In
contrast, tob2, a close homolog of tob, was expressed1D shows an example from 9-month-old mice). Further
analysis showed that the bone volume/total tissue vol- at a very low level in osteoblasts and MC3T3 cells (Figure
3B), suggesting little functional redundancy betweenume (BV/TV), a histomorphometric index of trabecular
bone mass, was increased in tob2/2 mice compared Tob and Tob2 in osteoblasts. Further Northern blot anal-
ysis of RNAs from 2T3 calvaria-derived osteoblast pre-with that of wild-type littermates, reaching to 140% and
250% of that in wild-type mice at 4 months and 9 months cursor cells, which differentiate into mature osteoblast
upon BMP2 stimulation (Ghosh-Choudhury et al., 1996;of age, respectively (Figure 2A). To examine whether the
absence of Tob affects the production of bone metabo- Chan et al., 1998), revealed that tob mRNA was rapidly
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Figure 1. Targeted Disruption of the tob Gene and Histological Analyses of Long Bones
(A) Schematic illustration of the targeting vector, wild-type genomic DNA, and targeted locus of the tob gene. The coding region of the Tob
protein is shown as a closed box.
(B) The 39 external probe (probe 1) was used for Southern blot analysis to detect homologous recombinants. Tail DNA from F1 progeny of
two heterozygote intercrosses were digested with EcoRV and subjected to Southern blot hybridization. The genotype for the tob locus is
indicated above each lane. Sizes of the DNA fragments are indicated on the left.
(C) Protein lysates prepared from primary embryonic fibroblasts were analyzed by immunoblotting with the anti-Tob antibodies.
(D) Plastic sections of tibiae from 9-month-old wild-type (left) and tob2/2 mice (right) were stained with Villanueva Goldner. The upper panels
show low-power views. The lower panels show high-power views. Scale bars in upper panels and lower panels indicate 0.5 mm and 0.1 mm,
respectively.
induced in response to recombinant human (rh) BMP2 cycloheximide downregulates repressor(s) for tob gene
expression or upregulates tob mRNA stability. In primarystimulation (Figure 3C). Induction of tob mRNA by
rhBMP2 was augmented in the presence of cyclohexi- calvaria-derived cells, rhBMP2-induced tob mRNA ex-
pression peaked at day 5 of rhBMP2 administration (Fig-mide (Figure 3D). The data suggest that de novo protein
synthesis is not required for this response and that ure 4C).
Cell
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Figure 2. Static and Dynamic Histomorphometric Analyses and In Vivo Analyses of Bone Formation
Histomorphometric markers of tob2/2 mice of two different ages (4 months and 9 months) were analyzed.
(A) Bone to tissue ratio (in volume) (BV/TV) reflects bone mass.
(B–D) Osteoblast surface (ObS/BS) and osteoclast surface (OcS/BS) indicate the portion of bone surface covered by osteoblasts and osteo-
clasts, respectively. Eroded surface (ES/BS) represents the function of osteoclasts.
(E) Bone formation rate was measured using sections double-labeled with calcein (see [F]). Open bars and closed bars represent wild-type
and tob2/2 mice, respectively.
(F) Two calcein-labeled mineralization fronts of tibiae trabecular bone from 9-month-old wild-type (left) and tob2/2 (right) mice were visualized
by fluorescent micrography. Bars represent means 6 SD. Asterisks indicate a statistically significant difference between wild-type and tob2/2
mice (*p , 0.05, **p , 0.02, ***p , 0.01, n 5 4). Statistical differences between groups were assessed by Student’s t test.
BMP2-Induced Osteoblast Proliferation and of Tob (Figure 4B). The ALP activity detected in the
presence of low concentration of rhBMP2 remained atDifferentiation Is Enhanced in Calvaria-
Derived Cells of tob2/2 Mice background levels by the seventh day of culture. How-
ever, the activity was greatly increased by the third weekTo elucidate the function of Tob in osteoblasts, we es-
tablished osteoblasts culture containing mostly osteo- of culture even without exogenous BMP2 (Figure 4A),
due probably to the endogenous BMP2 accumulatedblast precursors and/or immature osteoblasts (see Ex-
perimental Procedures) from calvariae of wild-type and during the culture period. We also addressed whether
Tob is involved in other signaling pathways relevant totob2/2 newborn mice. After culturing ex vivo for 21 days,
the cells were stained for alkaline phosphatase (ALP), bone formation. Treatment of calvaria-derived cells ex
vivo with TGF-b or bFGF, each of which is inhibitorya bone phenotype marker that precedes the onset of
mineralization. As shown in Figure 4A, the number of to osteoblast differentiation, decreased the basal ALP
activities in the presence or absence of Tob. TheALP-positive cells was remarkably increased in tob2/2
mice, suggesting that osteoblast differentiation was en- rhBMP2-induced ALP activity was suppressed (50%) by
TGF-b or bFGF in both wild-type and tob2/2 cells (Figurehanced in the absence of Tob.
BMPs belong to the transforming growth factor-b su- 4B). Thus, both TGF-b and bFGF signalings were normal
in tob2/2 calvaria-derived cells. We then examined theperfamily and are implicated in osteoblast differentia-
tion. We, therefore, postulated that Tob could be in- expression of the ALP and osteocalcin genes, which are
markers of mature osteoblasts, by Northern blot analysisvolved in BMP-induced osteoblast differentiation. To
test this possibility, calvaria-derived cultures containing of mRNAs from calvaria-derived cells (Figure 4C). The
induction of ALP by rhBMP2 was augmented in the cellsosteoblast precursors and/or immature osteoblasts of
wild-type or tob2/2 mice were exposed to rhBMP2 for of tob2/2 mice in comparison with that of wild-type mice.
The level of rhBMP2-induced osteocalcin expression7 days, and the ALP activities in cell extracts were exam-
ined. The rhBMP2-induced ALP activity was elevated in was also higher in calvaria-derived cells of tob2/2 mice
than in those of wild-type mice. Because BMP2 inducesthe absence of Tob in comparison to that in the presence
Negative Regulation of BMP Signaling by Tob
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Figure 3. Expression of tob mRNA
(A) Spatial expression of tob mRNA in bone
rudiment. A section of the metatarsal bone
prepared from a wild-type mouse embryo
(d18.5) was analyzed by in situ hybridization
using the antisense tob RNA probe. The up-
per panel shows a dark-field image, and the
lower panel shows a bright-field image. The
scale bar is 0.1 mm; arrowheads indicate the
bone collar.
(B) Expression of tob and tob2 mRNA in
MC3T3 cells, osteoblast precursor cells, and
osteoclasts as determined by Northern blot
hybridization.
(C) Northern blot of RNA from rhBMP2 (300
ng/ml)-stimulated 2T3 cells was probed by
tob cDNA.
(D) Northern blot of RNA isolated from BMP2-
stimulated 2T3 cells cultured in the absence
or presence of cychloheximide (CHX). The fil-
ter was probed by tob cDNA. CHX (20 mg/ml)
was added 30 min before rhBMP2 (300 ng/
ml) stimulation.
both proliferation and differentiation of osteoblast pro- type mice. rhBMP2 injection onto the calvariae of tob2/2
mice produced new bone approximately 2-fold greatergenitor cells (Yamaguchi et al., 1991), the effect of Tob
on mitogenic activity was examined. As shown in Figure in size than that produced by rhBMP2 on the wild-type
calvariae (Figure 5). In addition, the horizontal area of4D, BMP2-stimulated DNA synthesis in tob2/2 cells was
enhanced as compared with that of wild-type cells. the new bone induced by rhBMP2 in tob2/2 mice was
approximately 2-fold greater than that in wild-type miceTherefore, we tentatively conclude that Tob negatively
regulates BMP2-induced proliferation and differentia- (data not shown). These data demonstrate that BMP2-
induced bone formation is facilitated in the absencetion of the calvaria-derived cells.
of Tob, suggesting that Tob negatively regulates BMP
signaling in vivo.Increased Orthotopic Bone Formation by BMP2
in tob-Deficient Mice
To assess the effect of Tob on BMP2-induced bone Tob Represses BMP-Induced, Smad-Dependent
Transcriptionformation in vivo, rhBMP2 (5 mg) was injected onto the
center of the parietal bones of 3-day-old wild-type and Smad proteins play important roles in mediating BMP-
induced transcriptional activation of downstream genestob2/2 mice. Injection was carried out daily for 7 days,
and animals were sacrificed 2 days after the last injec- (Heldin et al., 1997; ten Dijke et al., 2000). We addressed
whether ectopic expression of Tob affects the activitytion. The rhBMP2-dependent de novo bone formation
was determined by image analysis and densitometry of Smad proteins. A Tob expression plasmid (pME-Tob)
and a BMP2-responsive reporter plasmid in which aand was expressed as the mean thickness of calvariae.
The thickness of calvariae of saline-injected tob2/2 mice luciferase gene was linked to the JunB promoter con-
taining four Smad binding elements (43 SBE) (Jonk etwas similar to that of saline-injected or untreated wild-
Cell
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Figure 4. Functional Analyses of Osteoblasts
(A) Ex vivo culture of osteoblast lineage cells derived from calvariae of newborn wild-type or tob2/2 mice. After cells were cultured for 3 weeks,
they were fixed and then stained for ALP.
(B) Effect of rhBMP-2 on the calvaria-derived cells. Calvaria-derived cells from newborn wild-type (open bars) or tob2/2 (closed bars) mice
were cultured for 7 days with various concentrations of rhBMP-2, and the ALP activity in cell extracts was measured. Bars represent means 6
SD. Asterisks indicate a statistically significant difference between wild-type and tob2/2 mice (*p , 0.05, **p , 0.03). Statistical differences
between groups were assessed by Student’s t test.
(C) Expression of the ALP, osteocalcin, and tob mRNAs in calvaria-derived cells in the presence or absence of rhBMP2. Calvaria-derived cells
from newborn wild-type or tob2/2 mice were treated with rhBMP2 (300 ng/ml) for the indicated periods of time.
(D) Effect of BMP2 (100 ng/ml) on [3H]thymidine incorporation in calvaria-derived cells. The cells in 0.5% FBS/a-MEM were treated with 100
ng/ml rhBMP2 and labeled with [3H]thymidine. Bars represent means 6 SD. Asterisks indicate a statistically significant difference between
wild-type and tob2/2 mice (*p , 0.05, n 5 4). Statistical differences between groups were assessed by Student’s t test.
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ated repression than that of 43 SBE promoter. Taken
together, these results suggest that Tob modulates
BMP2 signaling by suppressing the activity of Smad
proteins.
Ligand-Dependent Association of the Tob Protein
with R-Smads
To investigate possible interaction of Tob with Smad
proteins, we performed coimmunoprecipitation experi-
ments. The Flag-tagged Tob construct was transfected
into COS7 cells together with the expression plasmid
encoding 6Myc-tagged Smad1, 2, 3, 4, 5, or 8 proteins.
The lysates of transfectants were subjected to anti-Flag
immunoprecipitation followed by immunoblotting with
anti-Myc antibodies. As shown in Figure 6C, Tob was
coimmunoprecipitated with Smad1, 5, and 8. The level
of coimmunoprecipitation was enhanced by the active
form of the BMP receptor type IA, BMPR-IA(QD), sug-
gesting that the interaction between Tob and Smad1,
5, and 8 was facilitated by activation of BMP signaling.
The dependency of the interactions with Tob on activa-
tion of BMP signaling may differ among the Smad pro-
teins. Tob was also associated with Smad4 (Figure 6C).
Although Tob interacted with TGF-b-regulated R-Smads
(Smad2 and 3), these interactions were very weak as
compared with those between Tob and BMP-regulated
R-Smads (Figure 6C). Reciprocal coimmunoprecipita-
tion experiments with 6Myc-tagged Tob construct and
Flag-tagged Smad expression plasmids also revealed
the interaction between Tob and Smad1, 4, 5, and 8
Figure 5. In Vivo Stimulation of Bone Formation in Response to (Figure 6D; data not shown). The results demonstrate
BMP2 that Tob is a partner for Smad1, 4, 5, and 8 proteins in
(A) rhBMP2 (5 mg) was injected onto the center of the parietal bones the BMP pathway and that BMP signaling enhances
of 3-day-old wild-type or tob2/2 mice. Injection was carried out daily
formation of Tob/R-Smad complexes.for 7 days, and animals were sacrificed two days after the last
To further characterize the mechanism of interactioninjection. X-ray pictures were then recorded. Arrows indicate newly
between Tob and the Smad proteins, four deletion mu-formed bone.
(B) Calvariae bone volume at the injection site (newly formed bone) tants of Smad1 were produced (Figure 6D). While full-
was examined quantitatively with an image analyzer. Bars represent length Smad1 interacted with Tob in the presence of
means 6 SD. The difference in new bone formation in response BMPR-IA(QD), MH1 domain or MH1 plus linker did not
to BMP2 between wild-type and in tob2/2 mice was statistically
interact with Tob. In contrast, linker plus MH2 and MH2significant (p , 0.05). Statistical difference between groups was
domain interacted with Tob; Tob being associated withassessed by Student’s t test. Mean values for newly formed bone
linker plus MH2 more strongly than with MH2 domainin wild-type mice was set to 1.
alone. These data suggest that the MH2 domain is re-
sponsible for Smad interaction with Tob. The linker se-
quence may strengthen Tob association with Smad1,al., 1998) were transfected into C2C12 pluripotent mes-
although the linker sequence alone does not interactenchymal precursor cells (Figure 6A). Consistent with
with Tob (unpublished data). Because the degree ofprevious observations, rhBMP2 treatment of the C2C12
interaction of full-length Smad1 was less than that ofcells that had been transfected with the reporter con-
linker plus MH2, it is likely that MH1 domain is inhibitorystruct alone resulted in the stimulation of the luciferase
to the interaction. The inhibitory constraint might beexpression. The BMP2-triggered stimulation, however,
released by BMP receptor–mediated phosphorylationwas blocked by cotransfection of the Tob expression
of Smad1.vector. Ectopic expression of Smad proteins increased
the responsiveness of the 43 SBE. The ectopic Smad-
dependent activation was again repressed by exoge- Tob Regulates Subcellular Localization of R-Smads
We then examined the effect of Tob on subcellular local-nously expressed Tob. Similarly, when a 123 GCCG
promoter construct, a BMP-specific reporter activated ization of Smad proteins (Smad1, 5, and 8) in the ab-
sence or presence of BMP2 by confocal laser micros-only in the presence of excess Smads (Kusanagi et al.,
2000), was introduced into C2C12 cells, Smad proteins copy (Figure 7 for Smad1; data not shown for Smad5
and 8). When R-Smads were expressed exogenouslyalso potentiated transcription from the promoter both
in the absence and presence of rhBMP2 (Figure 6B). in C2C12 cells, these proteins were located in both
the nucleus and cytoplasm. After rhBMP2 stimulation,Such activation was also suppressed by coexpression
of Tob. The responsiveness of 123 GCCG promoter to R-Smads translocated into nucleus in some cells. Surpris-
ingly, when Tob was coexpressed, R-Smads localizedendogenous Smads was more sensitive to Tob-medi-
Cell
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Figure 6. Repression of Smad-Dependent Transcriptional Activation and Association of Tob with Smad Proteins
(A and B) Repression of the BMP2-regulated promoter activity by Tob. C2C12 cells were transfected with the reporter construct, 43 SBE Luc
(A), or 123 GCCG Luc (B) with Smad proteins and/or Tob expression plasmids. b-actin-b-gal plasmid was also cotransfected for normalization
of transfection efficiency. After incubation for 24 hr in the presence or absence of 300 ng/ml rhBMP2, luciferase and b-galactosidase activities
were determined. Mean luciferase activity of the cells transfected with the reporter plasmid alone and that received no BMP2 stimulation was
set to 10.
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to the nuclear bodies after BMP2 stimulation. Without teocalcin-deficient mice or ob/ob mice. Therefore, the
mechanism underlying the increased bone mass inrhBMP2 stimulation, R-Smads occasionally localized to
the nuclear bodies when coexpressed with Tob (data tob2/2 mice differs from that in osteocalcin-deficient
mice and ob/ob mice. Therefore, the tob2/2 mouse is anot shown). Strong expression of Tob may lead to trans-
location of R-Smads to nuclear bodies in the absence unique model that shows increased bone mass as a
result of increased numbers of osteoblasts. The findingof BMP2 stimulation. R-Smads never localized to the
nuclear bodies in the absence of Tob. In contrast, Smad4 may contribute to the development of therapeutic re-
agents for osteoporosis.did not localize to the nuclear bodies either in the pres-
ence or absence of Tob. Tob did not affect the subcellu-
lar localization of Smad2 and 3 in TGF-b responsive
Activated BMP2 Signaling in OsteoblastsMv1Lu cells either in the presence or absence of TGF-b
of tob2/2 Mice(data not shown). Thus, we conclude that Tob specifi-
Prominent expression of the tob mRNA in osteoblastcally regulates the subcellular localization of R-Smads
lineage cells (Figure 3) suggests that Tob plays a rolein a BMP2-dependent manner.
in regulation of osteoblast proliferation and/or differenti-
ation. Ex vivo culture of osteoblast precursors and/or
Discussion immature osteoblasts prepared from calvariae of new-
born mice reveals that BMP2-dependent proliferation
BMPs control fundamental processes such as meso- (Figure 4D) and differentiation (Figures 4A and 4B) of
derm patterning, left-right asymmetry, neurogenesis, these cells are enhanced in the absence of Tob. The ex
development of the kidney, gut, lung, and teeth as well vivo culture (Figure 4B) was from populations III and IV
as bone formation (Hogan, 1996). BMPs transduce sig- of calvariae (see Experimental Procedures) and con-
nals from membrane to nucleus through Smad proteins. sisted of osteoblast precursors and/or immature osteo-
However, the variety of functions of BMP signal can not blasts. When we used the populations V and VI that
be accounted for by Smads alone. Therefore, factors presumably contained mature osteoblasts, the effect of
that cooperate with Smads, Smad activators or Smad tob deficiency in the BMP2 responsiveness was less
inhibitors, are thought to be crucially important for BMP prominent (data not shown). Thus, Tob likely inhibits
function. Here, we provide evidence suggesting that Tob proliferation of osteoblast precursors and their differen-
is one such Smad regulator in osteoblast lineage cells. tiation into mature ALP-positive osteoblasts. However,
We show that (1) Tob is relevant to growth and differenti- the possibility that Tob inhibits the function of mature
ation of osteoblasts; (2) Tob is negatively involved in osteoblasts remains to be examined.
BMP2 signaling; (3) Tob interacts with Smad proteins The deficiency of Tob in osteoblast precursor and
and inhibits Smad-dependent transcription; (4) Tob col- immature osteoblasts in tob2/2 mice may explain their
ocalizes with R-Smads in nuclear bodies upon BMP2 increased osteoblast number as well as accelerated
stimulation. Therefore, Tob may form a transcription reg- bone formation. Consistently, BMP2-induced orthotopic
ulatory complex together with Smad proteins and con- bone formation is augmented in tob2/2 mice (Figure 5).
trol gene expression relevant to BMP2-induced osteo- These results suggest that cells in osteoblast lineage
blast growth and differentiation. of newborn tob2/2 mice were already hypersensitive to
BMP. It is likely that integral accumulation of the ele-
vated sensitivity to BMP results in apparent increase inTob as a Negative Regulator of Osteoblast Production
Bone histomorphometry analyses showed that numbers bone formation of relatively aged tob2/2 mice (Figure 2).
It should be also noted that environmental differenceand function of osteoclasts in tob2/2 mice are equivalent
to those in wild-type littermates. In contrast, the osteo- would explain apparent contradiction between the phe-
notypes observed in vivo and ex vivo. One such exampleblast surface and bone formation rate are increased
significantly in tob2/2 mice as compared to those in wild- is that osteopontin2/2 mice show normal bone in vivo
but display altered osteoclast formation ex vivo (Rittlingtype mice. There are some mouse models generated by
gene targeting in which the bone mass is increased. In et al., 1998).
As mice lacking the type I or type II BMP receptorthose mice, the increase in bone mass is due to impaired
osteoclast differentiation or function (Karsenty, 1999). are embryonic lethal (Mishina et al., 1995; Beppu et
al., 2000), BMPs are apparently necessary for normalIn only osteocalcin-deficient mice and ob/ob mice, bone
formation rate is increased without defects in differentia- development in mice. Nevertheless, tob2/2 mice were
alive at birth. Moreover, we did not observe ectopiction and function of osteoclasts (Ducy et al., 1996, 2000).
However, the osteoblast surface is not increased in os- bone formation in blood vessels or other tissues in
(C) The interactions of Flag-Tob with 6Myc-Smads in COS7 cells were examined by immunoprecipitation (IP) followed by immunoblotting
(Blot). BMP-RIA(QD) and TbR-I(TD) are constitutively active forms of BMP type IA receptor and TGF-b type I receptor, respectively, and were
tagged at the C terminus with the HA epitope. The top panel shows the interaction, the second panel from the top shows the Flag-Tob protein
immunoprecipitated by the anti-Flag antibody, and the lower two panels show expression of each indicated protein.
(D) Interaction of Tob with various Smad1 deletion mutants. FL, MH1, MH1 1 L, L 1 MH2, and MH2 denote full-length, MH1 domain, MH1
domain 1 linker region, linker region 1 MH2 domain, and MH2 domain, respectively. The left panel shows the protein structures of wild-type
Smad1 and various Smad1 deletion mutants. The right panel shows the interaction (upper panel) and expression of each indicated protein
analyzed by blotting the lysates (middle panel) or the anti-Flag immunoprecipitates (lower panel).
The efficiency of anti-FLAG immunoprecipitation (C and D) was similar between the lanes.
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Figure 7. Effect of Tob on the Subcellular Lo-
calization of Smad1
C2C12 cells were transfected with Flag-
Smad1 alone or together with Myc-Tob and
incubated either in the absence or presence
of BMP2 for 3 hr. Flag-Smad1 was visualized
with the anti-Flag antibody, and Tob was de-
tected with the anti-Tob antibody. The cells
were counterstained with TOTO-3 to identify
nuclei.
tob2/2 mice. It is possible that Tob2, a close homolog on the functional link between Tob and Cbfa1 in the
control of BMP signaling would help deepen our under-of Tob, has overlapping functions in tissues other than
bone. Indeed, both Tob and Tob2 are expressed in a standing of bone formation.
wide range of tissues (Matsuda et al., 1996; Ikematsu
et al., 1999). However, expression of tob2 mRNA was Tob Is a Novel Inhibitor of BMP/Smad Signaling
Several nuclear proteins have been implicated in tran-very low in osteoblasts (Figure 3B). In addition, unlike
tob, tob2 mRNA was not induced by BMP2 (data not scriptional repression of TGF-b/Smad signaling. For ex-
ample, TGIF, a homeodomain protein belonging to theshown). This would explain why tob2/2 mice show accel-
erated bone formation but not other phenotypes. Alter- TALE family, and the Ski oncoprotein were identified as
transcriptional corepressors of Smad2 and 3 (Massaguenatively, Tob may negatively regulate BMP signaling
only in osteoblasts and may be involved in osteoblast- and Wotton, 2000). TGIF and Ski interact with Smad2
and 3 in a TGF-b-dependent manner. TGIF and Ski re-specific transcription such as that regulated by Cbfa1
(reviewed in Komori and Kishimoto, 1998). It is worthy press TGF-b-induced transcription by recruiting HDAC
(Massague and Wotton, 2000). In contrast, no transcrip-to note that Cbfa1 can form complexes with Smads
(Hanai et al., 1999; Pardali et al., 2000). Further studies tional corepressors are identified in BMP/Smad signal-
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ing. Here, we demonstrate that Tob represses BMP- encoding alcohol dehydrogenase II (Denis, 1984). There-
fore, the interaction of the Tob/BTG family with Caf1induced, Smad-dependent transcription in osteoblasts
through its association with Smad proteins (Figure 6). may affect expression of genes involved in regulation
of cell growth and/or differentiation. Thus, in addition toTob interacts with Smad4 as well as Smad1, 5, and 8
(Figure 6C). The abilities of Smad1, 5, and 8 to heterooli- participating in BMP2 signaling through its association
with Smad proteins, Tob may affect a variety of tran-gomerize with Smad4 are not affected by coexpression
of Tob (Y.Y., unpublished data), suggesting that the Tob– scriptional machineries.
Smad complex likely consists of the R-Smad (Smad1,
Experimental Procedures5, and 8), Smad4, and Tob proteins.
Creation of tob2/2 Mice
Nuclear Bodies May Serve for Functional The 15 kbp genomic DNA of the tob gene (Yoshida et al., 1997)
Interaction of Smads and Tob was subcloned into the pBluescript. The neomycin resistance gene
It remains unclear how nuclear localization of Smads (PGK-neo) under control of the 3-phosphoglycerate kinase gene
promoter was inserted into the HincII site of the tob exon. Theis regulated. Smads form a transcriptional activation
resulting plasmid was linearized at the SalI site and electroporatedcomplex as described above. The proteins in Smad
into J1 embryonic stem (ES) cells (Li et al., 1992). After selectingcomplexes, including p300/CBP, HDACs, Ski, Sin3A,
G418-resistant ES clones, tob-targeted clones were identified by
and N-CoR, localize to nuclear bodies (Janknecht et al., Southern blot hybridization using probe 1 (shown in Figure 1A).
1998; Nomura et al., 1999). Interestingly, localization of Probe 2 and the neo probe were also used for Southern blot analysis
endogenous Smad2 and 3 to nuclear bodies is observed to confirm homologous recombination. The cells carrying the correct
mutation were injected into C57BL/6J blastocysts. Chimaeric off-(Janknecht et al., 1998). We show that Smad1, 5, and 8
spring were mated with C57BL/6J mice. Germline transmission oflocalize to nuclear bodies after BMP2 stimulation, when
the mutant allele was determined by Southern blot hybridization ofTob is coexpressed with Smad proteins (Figure 7). Taken
genomic DNA from tails of mice. Heterozygous F1 animals were
together, Tob is suggested to regulate localization of intercrossed to obtain homozygous (tob2/2) mice. Homozygosity for
R-Smads in the nucleus in a BMP2-dependent manner the tob knockout allele was confirmed by Southern blotting and
and to be involved in Smads-mediated transcriptional immunoblotting. Anti-Tob antibodies used were described by Mat-
suda et al. (1996).regulation.
On the basis of our results, we propose a model of
Bone Histomorphometryregulation of BMP signaling by Tob. BMP induces acti-
For in vivo fluorescent labeling, a single intraperitoneal injection ofvation and nuclear translocation of R-Smads, which re-
calcein (1.6 mg/kg body weight) was administrated at days 0 and
sults in transcriptional activation of various genes, in- 4 (4-month-old mice) or at days 0 and 7 (9-month-old mice). Mice
cluding the genes that stimulate proliferation and were sacrificed at day 6 (4-month-old mice) or at day 10 (9-month-
differentiation of osteoblasts. The tob gene is also in- old mice). Tibiae were fixed in 99.5% ethanol and embedded in
methylmethacrylate without decalcification. Longitudinal serial sec-duced in response to BMP2. Consequently, Tob accu-
tions (7 mm thick) were prepared using a microtome (Model 2050,mulates in the nucleus and recruits R-Smads to nuclear
Reichert Jung). The sections were stained with Villanueva Goldnerbodies by binding to the MH2 domain of the phosphory-
to discriminate between mineralized and unmineralized bone and to
lated R-Smads. This initiates a negative feedback mech- identify cellular components. Images were visualized by fluorescent
anism, allowing a precise and timely regulation of BMP light microscopy. Histomorphometry of bone sections was per-
signaling and, thus, proper bone formation. formed for at least eight optical fields of the secondary spongiosa
using a semiautomated system for bone analysis (Osteoplan II, Carl
Zeiss) at 200-fold magnification (Malluche et al., 1982). All sectionsImplications
were examined blind. Nomenclature, symbols, and units used areThe balance of positive and negative regulation of BMP
those recommended by the Nomenclature Committee of the Ameri-
signaling may be dependent in part on the relative levels can Society for Bone and Mineral Research (Parfitt et al., 1987).
of Smad inhibitors and Smad activators present in the
cells. Extracellular signals that regulate the activity of Cell and Tissue Culture
2T3 cells kindly provided by S. E. Harris (University of Texas Healtheither the Smad inhibitors or Smad activators would also
Science Center) and MC3T3 cells were cultured in a-MEM supple-affect this balance. Such signal-dependent modulation
mented with 10% FBS. C2C12 cells were cultured in DMEM supple-of Smad interaction with inhibitors and activators may
mented with 15% FBS. For the culture of osteoblast lineage cells,allow precise regulation of BMP-dependent transcrip-
calvariae from newborn mice were dissected aseptically and treated
tion. We propose that Tob, as a Smad-inhibitor, plays with 0.1% collagenase and 0.2% dispase. Four populations (I
a critical role in BMP2/Smad-regulated gene expression through VI) were obtained after sequential digestion times z10, 20,
30, 40, 50, and 60 min, respectively. Populations I and II, containingin osteoblasts. Recent studies revealed the involvement
periosteal fibroblastic cells, were discarded. Populations III and IV,of the Tob/BTG family proteins in transcriptional regula-
containing osteoblast precursors and/or immature osteoblasts, andtion. For example, the homeodomain-containing tran-
populations V and VI, containing mature osteoblasts, were culturedscription factor Hoxb9 is identified as a possible func-
in a-MEM containing 10% FCS and harvested at a subconfluent
tional partner of BTG1 and BTG2 (Prevot et al., 2000). stage. The calvaria-derived cells at passage 2 were replated at a
Furthermore, exogenously expressed BTG2 causes sig- density of 12,000 cells per cm2 in a-MEM containing 10% FCS, 50
mg/ml ascorbic acid, and 5 mM b-glycerophosphate for 3 weeks.nificant downregulation of the cyclin D1 transcript
For the assay of ALP activities, the calvaria-derived cells at passage(Guardavaccaro et al., 2000). Tob, Tob2, BTG1, and
2 were replated at a density of 1 3 104 cells/cm2. The cells wereBTG2 are associated with Caf1 (CCR4-associated factor
cultured in the presence or absence of various concentrations of1) (Bogdan et al., 1998; Rouault et al., 1998; Ikematsu
rhBMP2 (Yamanouchi Pharmaceutical Co. Ltd.). To prepare primary
et al., 1999). CCR4 (CCR, carbon catabolite repression) osteoclasts, bone marrow cells were cocultured in petri dishes with
consists of a complex of transcription factors required osteoblasts from calvariae in the presence of 1028 M vitamin D3.
Osteoclasts were purified as described (Tezuka et al., 1992).for expression of a number of genes, including the gene
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In Vivo Analyses of Bone Formation in Response to BMP2 rhBMP2. This work was supported by a grant for Advanced Cancer
Research from the Ministry of Education, Science, Sports, and Cul-Direct injection of growth factor onto the calvariae of newborn mice
was conducted as described previously (Noda and Camilliere, 1989). ture of Japan and grants from the Organization for Pharmaceutical
Safety and Research of Japan, the “Research for the Future” Pro-Briefly, rhBMP2 (5 mg in 10 ml saline) was injected onto the center
of the parietal bones of 3-day-old wild-type (n 5 5) or tob2/2 (n 5 gram of the Japan Society for the Promotion of Science (JSPS), and
the Research Fellowships of the JSPS for Young Scientists.5) mice. As a control, saline alone (10 ml) was injected onto the
center of the parietal bones of 3-day-old wild-type (n 5 6) or tob2/2
(n 5 7) mice. In some mice, a higher dosage of rhBMP2 (10 mg) was Received June 26, 2000; revised November 10, 2000.
injected into wild-type (n 5 2) or tob2/2 (n 5 2) mice. For these
experiments, rhBMP2 was purchased from Genetics Institute. Injec- References
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